Buchy P
GSK Vaccines R&D, 150 Beach Road, unit 22-00, 189720, Singapore, Singapore.
Bull Soc Pathol Exot. 2016 Oct;109(4):256-261. doi: 10.1007/s13149-016-0521-2. Epub 2016 Sep 19.
The Ebola epidemic that occurred in West Africa between 2013-2016 significantly accelerated the research and development of Ebola vaccines. Few dozens of clinical trials have been recently conducted leading to opportunities to test several new vaccine candidates. Other vaccines are still in early development phases (table 1). This paper provides an overview of the new developments in that area.
2013年至2016年在西非爆发的埃博拉疫情显著加速了埃博拉疫苗的研发。最近进行了几十项临床试验,为测试几种新的候选疫苗提供了机会。其他疫苗仍处于早期研发阶段(表1)。本文概述了该领域的新进展。